Literature DB >> 9102218

Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells.

A Bagnato1, R Tecce, V Di Castro, K J Catt.   

Abstract

Endothelin 1 (ET-1) is produced in ovarian cancer cell lines and has been shown to act through ET(A) receptors as an autocrine growth factor to promote tumor cell proliferation in vitro. In OVCA 433 cells, the efficacy of ET-1 as a stimulus of [3H]thymidine incorporation was equivalent to that of epidermal growth factor. ET-1 also stimulated the rapid expression of c-fos, an action mediated by ET(A) receptors. The mitogenic action of ET-1 was not mediated by a pertussis toxin-sensitive G protein. An analysis of the effects of inhibition and depletion of protein kinase C (PKC) on mitogenic responses demonstrated that PKC was necessary but not sufficient for maximal stimulation by ET-1. In quiescent OVCA 433 cells, ET-1-induced stimulation of [3H]thymidine incorporation was prevented by two structurally distinct inhibitors of tyrosine kinase, herbimycin A and genistein. These results indicate that both PKC and protein tyrosine kinase participate in ET-1-stimulated mitogenic signaling. ET-1 rapidly stimulated tyrosine phosphorylation of several cellular proteins, among which p125FAK and p42 mitogen-activated protein kinase were identified. The additivity between the potent mitogenic actions of ET-1 and epidermal growth factor is consistent with the independence of their signal transduction pathways in ovarian cancer cells. These findings also indicate that intracellular signaling between the ET(A) receptor and a yet unidentified tyrosine kinase is involved in the mitogenic response to ET-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9102218

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

Review 1.  Angiogenesis in cancer: the role of endothelin-1.

Authors:  K Dawas; M Loizidou; A Shankar; H Ali; I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

2.  Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes.

Authors:  Ngoc-Han Ha; Vasudha S Nair; Divijendra Natha Sirigiri Reddy; Prakriti Mudvari; Kazufumi Ohshiro; Krishna Sumanth Ghanta; Suresh B Pakala; Da-Qiang Li; Luis Costa; Allan Lipton; Rajendra A Badwe; Suzanne Fuqua; Margaretha Wallon; George C Prendergast; Rakesh Kumar
Journal:  Cancer Res       Date:  2011-10-17       Impact factor: 12.701

3.  Ontogeny of endothelins-1 and -3, their receptors, and endothelin converting enzyme-1 in the early human embryo.

Authors:  M Brand; J M Le Moullec; P Corvol; J M Gasc
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

4.  Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells.

Authors:  A Bagnato; L Rosanò; V Di Castro; A Albini; D Salani; M Varmi; M R Nicotra; P G Natali
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

5.  Modulation of human colon tumor-stromal interactions by the endothelin system.

Authors:  G Egidy; L Juillerat-Jeanneret; J F Jeannin; P Korth; F T Bosman; F Pinet
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

6.  Role of Lactoferrin in the Carcinogenesis of Triple-Negative Breast Cancer.

Authors:  Srirupa Hari Gopal; Salil K Das
Journal:  J Cancer Clin Trials       Date:  2016-07-14

Review 7.  The effect of phytoestrogens on the female genital tract.

Authors:  J L Burton; M Wells
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

8.  The endothelin system in Morris hepatoma-7777: an endothelin receptor antagonist inhibits growth in vitro and in vivo.

Authors:  Thiemo Pfab; Gisela Stoltenburg-Didinger; Christoph Trautner; Michael Godes; Christian Bauer; Berthold Hocher
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

Review 9.  Activated epidermal growth factor receptor in ovarian cancer.

Authors:  Laurie G Hudson; Reema Zeineldin; Melina Silberberg; M Sharon Stack
Journal:  Cancer Treat Res       Date:  2009

10.  Effect of endothelin-1 on cyclooxygenase-2 expression in human hormone refractory prostate cancer cells.

Authors:  Qi Su; Rui-Peng Jia; Jianzhong Lin; Lu-Wei Xu; Zi-Zheng Wang; Wen-Cheng Li; Shu-Kui Wang
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.